Lastly, the deployment of new techniques and practices in therapy (radiotherapy, ITR) remains a subject of vigilance for ASN, which will endeavour to promote any measures aiming to better assess the radiation protection risks and allow a better demonstration of their advantages compared with the existing techniques. To this end, ASN will continue its work in cooperation with the various institutional actors in the health sector, the professional organisations and assisted by its groups of experts, particularly the Canpri, particularly with regard to flash radiotherapy and adaptive radiotherapy. In nuclear medicine, which is witnessing the emergence of new vectors and radionuclides for therapeutic purposes, forecasts of growth in the number of patients eligible for these new treatments with methods of treatment on an outpatient basis and limited infrastructure, ASN underlines the importance of anticipating the radiation protection risks for the patients and carers and comforters, for the workers, and with regard to fitting out the facilities and the management of effluents and waste. It has referred this matter to the GPRP, and keeps track of the European work carried out for the SimpleRad project and maintains a dialogue with the nuclear medicine actors to reiterate the regulatory framework and check that it remains in keeping with the developments. ASN Report on the state of nuclear safety and radiation protection in France in 2023 239 • 07 • Medical uses of ionising radiation 07 05 15 08 11 04 14 06 13 AP 03 10 02 09 12 01
RkJQdWJsaXNoZXIy NjQ0NzU=